Vernalis (R&D) Limited

Vernalis (R&D) Limited (Vernalis Research) is a Cambridge, UK-based biotech company specializing in pre-clinical drug discovery, primarily through fragment-based and structure-based approaches. It operates as a contract research organization (CRO) for pharmaceutical and biotech partners, supporting programs from target identification through lead optimization and candidate selection. Vernalis has delivered multiple clinical candidates in oncology and neurodegeneration, some of which progressed into clinical trials under partner companies. The company is a subsidiary of HitGen Inc. and maintains active collaborations with major pharma and biotech firms. It has no marketed products and does not conduct late-stage clinical development internally.